Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S26 pseudogene 18 (RPS26P18) is a non-functional, processed pseudogene in the human genome that is homologous to the ribosomal protein S26 (RPS26) gene[2][5]. RPS26 is a component of the small 40S subunit of the ribosome and is involved in mRNA translation[1][3]. However, “pseudogene 18” does not encode a functional protein and is not associated with any known cellular or disease function[2][5]. It serves primarily as a genomic remnant arising from gene duplication or retrotransposition and is part of a larger family of similar ribosomal protein pseudogenes dispersed through the genome[1][4]. Pseudogenes are sometimes useful in evolutionary biology or genomics as landmarks but do not have therapeutic, diagnostic, or clear biological utility. Key distinction: The functional ribosomal protein S26 (RPS26) is linked with ribosome assembly and genetic disease (e.g., Diamond-Blackfan anemia), but RPS26P18 is an inactive, non-coding pseudogene unrelated to these functions[1][3][4].
None (no drug action reported against this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 18 (RPS26P18).